Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Demographic and clinical characteristics of 53 patients included in the study submitted to radical prostatectomy to treat prostate cancer

From: miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

Age (years) Mean 65.4
Min - Max 50 - 79
PSA (ng/ml) Mean 11.0
Min - Max 2.0 – 37.0
<10 n (%) 27 (50.1)
≥10 n (%) 26 (49.9)
Stage  
pT2 n (%) 22 (42.3)
pT3 n (%) 30 (57.7)
Gleason Score  
< 7 n (%) 22 (41.5)
≥ 7 n (%) 31 (58.5)